These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12451320)

  • 21. Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators.
    Riegger GA; Bouzo H; Petr P; Münz J; Spacek R; Pethig H; von Behren V; George M; Arens H
    Circulation; 1999 Nov; 100(22):2224-30. PubMed ID: 10577995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
    Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Yusuf S; Pocock S;
    Lancet; 2003 Sep; 362(9386):759-66. PubMed ID: 13678868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking augments sympathetic nerve activity in patients with coronary heart disease.
    Shinozaki N; Yuasa T; Takata S
    Int Heart J; 2008 May; 49(3):261-72. PubMed ID: 18612184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
    McMurray JJ; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA;
    Lancet; 2003 Sep; 362(9386):767-71. PubMed ID: 13678869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2005 Mar; 45(5):661-7. PubMed ID: 15734608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited effect of systemic beta-blockade on sympathetic outflow.
    Tank J; Diedrich A; Schroeder C; Stoffels M; Franke G; Sharma AM; Luft FC; Jordan J
    Hypertension; 2001 Dec; 38(6):1377-81. PubMed ID: 11751721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pioglitazone on arterial baroreflex sensitivity and sympathetic nerve activity in patients with acute myocardial infarction and type 2 diabetes mellitus.
    Yokoe H; Yuasa F; Yuyama R; Murakawa K; Miyasaka Y; Yoshida S; Tsujimoto S; Sugiura T; Iwasaka T
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):563-9. PubMed ID: 22361751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of angiotensin II receptor antagonist on insulin sensitivity and sympathetic activity in spontaneously hypertensive rats].
    Sasaki K; Kushiro T; Nakagawa S; Kanmatsuse K
    Nihon Jinzo Gakkai Shi; 1999 Oct; 41(7):692-6. PubMed ID: 10572394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of endothelin-1 in mediating changes in cardiac sympathetic nerve activity in heart failure.
    Abukar Y; May CN; Ramchandra R
    Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(1):R94-9. PubMed ID: 26468257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
    Grassi G; Cattaneo BM; Seravalle G; Lanfranchi A; Pozzi M; Morganti A; Carugo S; Mancia G
    Circulation; 1997 Aug; 96(4):1173-9. PubMed ID: 9286946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
    J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?
    Fu Q; Zhang R; Witkowski S; Arbab-Zadeh A; Prasad A; Okazaki K; Levine BD
    Hypertension; 2005 Apr; 45(4):513-21. PubMed ID: 15738344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of AT1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure.
    Murakami H; Liu JL; Zucker IH
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R303-9. PubMed ID: 8760234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
    Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery--investigation using a candesartan change-over study.
    Sezai A; Soma M; Hata M; Yoshitake I; Unosawa S; Wakui S; Shiono M
    Ann Thorac Cardiovasc Surg; 2011; 17(5):487-93. PubMed ID: 21881353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in baroreflex function by an oral angiotensin receptor antagonist in rats with myocardial infarction.
    Nishizawa M; Kumagai H; Ichikawa M; Oshima N; Suzuki H; Saruta T
    Hypertension; 1997 Jan; 29(1 Pt 2):458-63. PubMed ID: 9039142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: A role for angiotensin II.
    Liu JL; Irvine S; Reid IA; Patel KP; Zucker IH
    Circulation; 2000 Oct; 102(15):1854-62. PubMed ID: 11023943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.